Edition:
India

Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

121.48USD
1:27am IST
Change (% chg)

$-1.43 (-1.16%)
Prev Close
$122.91
Open
$122.90
Day's High
$122.90
Day's Low
$118.70
Volume
55,515
Avg. Vol
97,816
52-wk High
$194.56
52-wk Low
$105.19

About

BeiGene, Ltd. is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company's main products include Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $7,277.87
Shares Outstanding(Mil.): 60.00
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates